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Immunization generates several memory T cell subsets that differ in their migratory properties,
anatomic distribution, and, hence, accessibility to investigation. In this issue, Steinert et al. demon-
strate that what was believed to be a minor memory cell subset in peripheral tissues has been
dramatically underestimated. Thus, current models of protective immunity require revision.In 1936, Literary Digest, a political maga-
zine, surveyed a quarter of the U.S.
voting population and predicted that
Senator Alfred Landon would capture
55% of the vote and defeat the incum-
bent Franklin D. Roosevelt. On Election
Day, Roosevelt soundly defeated Landon
with 61% of the vote, the largest margin
of victory in history at the time. How
could the magazine’s polling have been
this embarrassingly misleading? The
answer lay in the methodology that was
used, particularly the inherently biased
sampling of respondents whose names
could be easily obtained from phone
directories and automobile registration
records, a group that was not represen-
tative of contemporary U.S. voters
(Squire, 1988). This kind of bias easily
creeps into political polls, and careful
measures are now being taken to avoid
such pitfalls.
In science, however, we sometimes
forget that the methodologies we use
can similarly skew what appear to be
objective outcomes. In this issue, Steinert
et al. (2015) provide a telling example of
how a widely used analytical approach
in cellular immunology has distorted the
field’s concepts of immune surveillance
by memory T cells. The authors demon-
strate that the traditional approach relied
on data extrapolation from apparently
non-representative samples and the use
of unreliable surrogate markers for func-
tional definitions of cellular subsets.
Immune challenges, such as infections
or vaccination, result in the activation
(also called ‘‘priming’’) of naive T lympho-
cytes in secondary lymphoid organs
(SLOs). Some of the activated T cells702 Cell 161, May 7, 2015 ª2015 Elsevier Incdifferentiate into so-called memory cells,
which have the capacity to persist for
many years after the original challenge
has been cleared. Importantly, memory
cells provide enhanced protection against
re-infection with the same pathogen.
Memory T cells are usually classified into
three distinct subsets based on each sub-
set’s unique migratory behavior (Mueller
et al., 2013; Sallusto et al., 1999). Central
memory T cells (TCM) circulate through
blood and SLOs, including the lymph no-
des, which collect lymph fluid from the
body’s peripheral tissues. Effector mem-
ory T cells (TEM) lack lymph node homing
capacity; TEM are found in blood and
spleen and were widely assumed to also
survey non-lymphoid tissues. More
recently, a third memory T cell population
was identified: the tissue resident mem-
ory T cells (TRM). TRM arise soon after
priming from activated effector cells that
seed peripheral tissues. Unlike TEM, which
have been thought to visit such tissues
transiently, TRM are largely sessile and
do not circulate. Recent studies revealed
that, at least in some settings, TRM are
more effective at protecting non-
lymphoid tissues from pathogens than
the migratory TCM and TEM (Mackay
et al., 2012). This posed an apparent
conundrum because TRM were believed
to be sparse and vastly outnumbered by
their neighboring parenchymal cells.
Since T cells must directly touch every in-
fected cell that they are meant to protect,
how could the rare TRM be so effective at
protecting the abundant somatic cells
from invading pathogens?
An early glimpse of the overall distribu-
tion of the memory T cell repertoire in.immunized mice was provided in 2001
by two classical studies that showed
that most memory cells reside in periph-
eral tissues and not in SLOs (Masopust
et al., 2001; Reinhardt et al., 2001). One
of these studies tracked CD4 memory
cells by immunohistochemical analysis
of whole-body sections of immunized
mice (Reinhardt et al., 2001), a tour-de-
force strategy that yields unbiased re-
sults but is technically highly demanding.
Thus, more recent studies in the field
have resorted to quantifying memory
T cells in single-cell suspensions of tis-
sues that were freshly harvested from
immunized mice (Figure 1). To distin-
guish between the different memory cell
subsets, researchers stain the recovered
T cells with antibodies to lymph node
homing receptors (expressed on TCM,
not TEM or TRM) and to two surface
markers, CD69 and CD103, which were
thought to be diagnostic for TRM. Several
studies have distinguished between
extra- and intravascular memory cells
by intravenously injecting an antibody to
a common T cell surface moiety (e.g.,
CD45) coupled to a large fluorophore,
such as phycoerythrin, a few minutes
prior to sacrificing the animal. The in-
jected antibody remains confined to the
vessel lumen during this brief time inter-
val, so it stains selectively the intravas-
cular subset (Anderson et al., 2014).
The extravascular T cells, which remain
unstained, are composed of non-migra-
tory TRM and additional memory cells
that access peripheral tissues sporadi-
cally from the blood and eventually
depart via the draining lymphatics
(Mackay et al., 1988). The latter have
Figure 1. A Comparison of Analytical Methods to Quantify Memory T Cells in Immunized
Mice
Colored spheres represent memory T cells that are non-randomly dispersed throughout the body.
Different colors symbolize different subsets of memory T cells (only two subsets are shown for simplicity).
(A) In the most common approach in the field, a tissue sample is enzymatically digested and mechanically
dissociated to generate a single-cell suspension, while indigestible tissue stroma is discarded. In this
approach, T cell isolation is often incomplete, isolation efficiency can vary between T cell subsets, and
information regarding the spatial localization of the T cells within the tissue and body is not preserved.
(B) Tissue samples are sectioned and analyzed by immunostaining and quantitative microscopy. Data
Cellong been assumed to be recruited from
the TEM subset, although experimental
evidence has largely been lacking.
These standard procedures for mem-
ory cell isolation have been relying on
two assumptions: (1) T cell isolation from
tissue-derived cell suspensions is effi-
cient and yields every memory subset
without bias, and (2) the presence and
identity of TRM is faithfully reported by
CD69 and/or CD103 expression com-
bined with lack of intravascular staining.
In this issue, Steinert et al. test both
assumptions by comparing the frequency
and phenotype of each memory subset
recovered from traditional tissue sus-
pensions with results obtained using
exacting quantitative microscopy of
immunostained tissue sections (Figure 1).
The results are unexpected. The number
of TRM that are found in sections of
some peripheral tissues, such as the
female reproductive tract (FRT), is much
larger (by as much as 60-fold) than
the number of TRM that can be recov-
ered from single-cell preparations of the
same tissues. This discrepancy reflects
a dramatic loss of T cells during tissue
processing, whereby many cells are pre-
sumably either killed or discarded with
indigestible tissue stroma. T cell loss
disproportionately affects the recovery
of TRM, resulting in over-representation
of other memory subsets, particularly
those in the intravascular compartment.
Furthermore, when the two analytical
techniques are applied to other tissues,
such as spleen and lymph nodes, both
approaches yield comparable numbers
of memory cells. These findings imply
that the standard model of peripheral
T cell memory, which has been largely
based on analyses of tissue suspensions,
not only underestimates the overall size of
the memory pool, but also is based on
a severely skewed perception of sub-
set abundance both between differentfrom the analyzed region/tissue is extrapolated to
the whole organ and even the whole mouse.
Information regarding the density and spatial
distribution of T cell subsets within the analyzed
sample is well conserved, but results may not
necessarily be representative of the whole mouse.
(C) Analysis of whole-body sections bymicroscopy
can provide information regarding the spatial
distribution of T cell subsets within an entire
animal; however, the approach is technically very
demanding.
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anatomic regions and within any given
tissue.
Steinert et al. also interrogate the
second assumption: that TRM faithfully
express CD69 and/or CD103 and are not
accessible to intravascular antibody. Us-
ing parabiotic pairs of congenic mice,
which were surgically joined to establish
a shared blood circulation, the authors
discover that a sizeable fraction of TRM
express neither CD69 nor CD103, and
some TRM, especially in the kidney and
liver, actually appear to reside within the
intravascular space.
These findings have implications for
how immunologists think about T cell
surveillance of tissues, particularly with
regard to TRM. For example, in the FRT,
isolation-based methods had estimated
that there is one TRM for every 20,000
nucleated cells, while tissue microscopy
performed by Steinert et al. reveals that
there is one TRM for every300 nucleated
cells. Assuming that TRM within the FRT
scan cells at a similar rate to those in the
skin (Ariotti et al., 2012), isolation-based
methods project that TRM would require704 Cell 161, May 7, 2015 ª2015 Elsevier Inc1 month to scan every cell in the FRT.
In contrast, the tissue microscopy data
imply that TRM scan the FRT in its entirety
within 12 hr, an estimate that is much
more consistent with the reported effec-
tiveness of TRM to protect non-lymphoid
tissues (Mackay et al., 2012).
Steinert and colleagues thus provide a
much-needed reality check for immunolo-
gists. Their findings will have to be taken
into account when evaluating immune
responses to vaccines and pathogens,
and it will be important to determine their
impact on our understanding of allergic
and autoimmune diseases, as well as im-
muno-oncology.
Even though 80 years have passed
since the Literary Digest fiasco, this study
provides a stern reminder that sample
bias is not a fiction of the past but remains
to this day a fact to be reckoned with—by
scientists and voters alike.REFERENCES
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Cancer is known for opportunistically utilizing resources from its surroundings for its own growth
and survival. In this issue of Cell, Venkatesh et al. demonstrate that this also occurs in the brain,
identifying neuronal activity-induced secretion of neuroligin-3 as a novel mechanism promoting
glioma proliferation.Cancer is notorious for hijacking normal
biological processes to promote tumor
cell survival, migration, and proliferation.
Cancer cells release angiogenic factors
that promote blood vessel formation to
support their own survival and upregulate
molecules normally expressed by healthy
cells to evade immune detection. In their
recent study, Venkatesh et al. (2015)
reveal that cancer cells also take advan-
tage of neuronal activity, the most essen-tial aspect of brain function, in order to
proliferate. The authors demonstrate that
optogenetic stimulation of neurons can
promote the growth of human high-grade
gliomas (HGGs) by inducing the secretion
of mitogenic factors.
This study was initiated following the
discovery that neuronal activity stimulates
the proliferation of oligodendrocyte pre-
cursor cells (OPCs) and neuronal precur-
sor cells (NPCs) in vivo (Gibson et al.,2014), cells that can give rise to gliomas
(Cuddapah et al., 2014). Both studies uti-
lized optogenetic strategies to increase
neuronal activity by stimulating channelr-
hodopsin-expressing neurons with blue
light (Figure 1A). This approach enables
the activation of subsets of neurons in
defined circuits in a physiological manner
and allows for comparisons between
different circuits or regions from within
the same brain. Importantly, this method
